Test Price
2,800 AED✅ Home Collection Available
FGD1 Gene Faciogenital Dysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FGD1 لتشوه الوجه والأعضاء التناسلية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Certainty 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing, aligned with 2026 DHA/MOHAP guidelines.
- ✓ Premium Logistics: Hospital‑Grade Home Collection by ISO‑Certified Cold‑Chain Phlebotomy (8 AM – 11 PM daily).
- ✓ Clinical Guidance: Telephonic post‑test interpretation session with a genetic specialist.
- ✓ Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
يوفر هذا الاختبار دقة تشخيصية عالية لتحديد طفرات جين FGD1 المسببة لمتلازمة آرسكوغ-سكوت، مع استشارة وراثية متكاملة وسحب دم منزلي مبرد معتمد من هيئة الصحة بدبي.
Test Overview
The FGD1 Gene Faciogenital Dysplasia Genetic Test employs next‑generation sequencing to detect pathogenic variants in the FGD1 gene, the molecular cause of Aarskog‑Scott syndrome (faciogenital dysplasia). This test delivers a definitive molecular diagnosis for affected individuals and carriers, guiding clinical management and family planning. يُعد هذا التحليل الجيني المرجعي الذهبي لتأكيد تشوه الوجه والأعضاء التناسلية وراثياً.
| Parameter | Our Test – UAE Premium | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing), full coding region ± copy number | Sanger sequencing (single‑exon, lower sensitivity) |
| Diagnostic Sensitivity | >99.9% for FGD1 point mutations & small indels | 85–90% (misses deep intronic variants) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Types Accepted | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | Whole Blood Only |
| Pre‑Test Genetic Counselling | Included (pedigree chart & informed consent) | Often not included |
Physician Insight & Safety Protocol
“I understand that pursuing a genetic diagnosis for your child can be deeply personal. The FGD1 test provides a clear molecular answer, but it must always be interpreted alongside a comprehensive physical exam and family history. A positive result does not stand alone—it opens the door to tailored care, early intervention, and informed reproductive choices. Please never stop prescribed medications without your doctor’s approval.”
— Dr. Prabhakar Reddy, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing clinical care.
Patient Safety Exclusion Criteria & Urgent Red Flags
- Exclusion: Inability to obtain valid informed consent (e.g., minors without legal guardian present).
- Exclusion: Active uncontrolled infection at venipuncture site; sample haemolysis may lead to recollection.
- ER Red Flag: Sudden change in facial or genital swelling, severe pain, or acute urinary retention – proceed directly to emergency care.
- ER Red Flag: New‑onset seizures or neurological deterioration in a dysmorphic child.
Patient FAQ & Clinical Guidance
1. What is the FGD1 gene test and why is it performed?
This NGS-based genetic test identifies FGD1 gene mutations responsible for Aarskog‑Scott syndrome, providing a definitive molecular diagnosis. It is indicated when a child presents with characteristic facial features (hypertelorism, broad nasal bridge), short stature, and genital anomalies. The test also helps determine carrier status in relatives and guides prenatal/preimplantation genetic diagnosis.
يحدد هذا الاختبار الجيني القائم على التسلسل الجيني طفرات جين FGD1 المرتبطة بمتلازمة آرسكوغ-سكوت لتأكيد التشخيص الوراثي بدقة.
يُجرى عند ظهور ملامح وجهية مميزة وقصر قامة وتشوهات تناسلية لتأكيد الإصابة أو الكشف عن حاملي الطفرة.
2. How is the sample collected and what is the turnaround time?
A certified phlebotomist collects a standard blood sample (or dried blood spot) at your home between 8 AM and 11 PM, with same‑day cold‑chain transport to our ISO‑accredited lab. The entire process from collection to lab receipt ensures DNA integrity. Results are ready in 3–4 weeks. You may also submit previously extracted DNA or a FTA card.
يتم سحب عينة دم بسيطة بالمنزل عبر فريق تمريض مرخص بين الساعة 8 صباحاً و11 مساءً، مع شحن مبرد لمختبرنا المعتمد.
تظهر النتائج خلال 3 إلى 4 أسابيع، مع إمكانية استخدام الحمض النووي المستخلص أو بقعة الدم الجافة.
3. How reliable are the results and what does a positive finding mean?
The achieves over 99.9% diagnostic sensitivity for FGD1 mutations, validated by ISO 9001:2015 protocols and continuous external quality assessment. A positive result confirms the genetic basis of Aarskog‑Scott syndrome, enabling targeted therapy, surveillance for associated complications (e.g., orthopedic issues, cardiac anomalies), and accurate recurrence risk counselling. Negative results may require further investigation for differential diagnoses.
يحقق الاختبار حساسية تشخيصية تتجاوز 99.9% وفق معايير الجودة العالمية ISO 9001:2015، مما يضمن موثوقية النتائج.
النتيجة الإيجابية تؤكد وجود الطفرة وتوجه الرعاية الطبية وتقييم المخاطر الوراثية للعائلة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians